| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.3810/PGM.2010.07.2172 |
| P698 | PubMed publication ID | 20675968 |
| P50 | author | Ahmed Z Elmaadawi | Q57658556 |
| P2093 | author name string | Rif S El-Mallakh | |
| Yonglin Gao | |||
| Muruga Loganathan | |||
| Kavita Lohano | |||
| P2860 | cites work | Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) | Q21999020 |
| Practice Parameter for the Assessment and Treatment of Children and Adolescents With Bipolar Disorder | Q22242775 | ||
| National trends in the outpatient diagnosis and treatment of bipolar disorder in youth | Q28244462 | ||
| Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study | Q28259349 | ||
| Antidepressant-induced mania, rapid cycling and the serotonin transporter gene polymorphism | Q44440922 | ||
| Antidepressant-associated chronic irritable dysphoria (acid) in bipolar disorder: a case series | Q45263088 | ||
| Is psychopharmacologic treatment associated with neuropsychological deficits in bipolar youth? | Q45941977 | ||
| Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127). | Q46086886 | ||
| Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression | Q46200033 | ||
| The long-term natural history of the weekly symptomatic status of bipolar I disorder | Q46317822 | ||
| Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes | Q46775574 | ||
| Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies | Q46801835 | ||
| Serotonin transporter linked promoter (polymorphism) in the serotonin transporter gene may be associated with antidepressant-induced mania in bipolar disorder | Q46880955 | ||
| Molecular determinants of energy homeostasis | Q48480935 | ||
| Latent class analysis shows strong heritability of the child behavior checklist-juvenile bipolar phenotype. | Q50939077 | ||
| Evaluating the validity of blood-based membrane potential changes for the identification of bipolar disorder I. | Q51909988 | ||
| The two manias: a study of the evolution of the modern concept of mania. | Q52102312 | ||
| A 24-Week Open-Label Extension Study of Olanzapine-Fluoxetine Combination and Olanzapine Monotherapy in the Treatment of Bipolar Depression | Q57479549 | ||
| Divalproex, lithium and suicide among Medicaid patients with bipolar disorder | Q59150119 | ||
| Six-month stability and outcome of a prepubertal and early adolescent bipolar disorder phenotype | Q73125623 | ||
| The emerging epidemiology of hypomania and bipolar II disorder | Q77700788 | ||
| GAMIAN-Europe/BEAM survey II: cross-national analysis of unemployment, family history, treatment satisfaction and impact of the bipolar disorder on life style | Q80995801 | ||
| Olanzapine in PDD | Q93900525 | ||
| Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial | Q28259736 | ||
| Effectiveness of adjunctive antidepressant treatment for bipolar depression | Q28295408 | ||
| Structural Brain Magnetic Resonance Imaging of Limbic and Thalamic Volumes in Pediatric Bipolar Disorder | Q28953417 | ||
| A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network. | Q30884720 | ||
| Gray matter, white matter, brain, and intracranial volumes in first-episode bipolar disorder: a meta-analysis of magnetic resonance imaging studies | Q33516162 | ||
| Pharmacological and non-drug treatment of child bipolar I disorder during prospective eight-year follow-up | Q33805416 | ||
| Historical perspectives and natural history of bipolar disorder | Q33920209 | ||
| Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire | Q33923768 | ||
| Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression | Q33949128 | ||
| Bipolarity from ancient to modern times: conception, birth and rebirth | Q33957680 | ||
| Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression | Q34275783 | ||
| Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial | Q34582156 | ||
| Bipolar II disorder: current and future treatment options | Q34590010 | ||
| Treatment-emergent mania/hypomania during antidepressant monotherapy in patients with rapid cycling bipolar disorder | Q34609823 | ||
| Research diagnostic criteria: rationale and reliability | Q34711463 | ||
| Clinical course of children and adolescents with bipolar spectrum disorders | Q34814593 | ||
| Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression | Q35012213 | ||
| Costs of bipolar disorder | Q35154704 | ||
| Teaching Family Physicians About Mood Disorders: A Procedure Suite for Behavioral Medicine | Q35663821 | ||
| Mood state at study entry as predictor of the polarity of relapse in bipolar disorder | Q35985601 | ||
| Treatment guidelines for children and adolescents with bipolar disorder | Q36052032 | ||
| Antipsychotic medications in the treatment of bipolar disorder | Q36611891 | ||
| Antidepressants and suicidal behavior in bipolar disorder | Q36624146 | ||
| Co-occurrence of bipolar and attention-deficit hyperactivity disorders in children | Q36677656 | ||
| Family-focused treatment for adolescents with bipolar disorder: results of a 2-year randomized trial | Q37029242 | ||
| A critical update on psychological interventions for bipolar disorders | Q37631793 | ||
| Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study. | Q38382524 | ||
| N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity | Q40039619 | ||
| Defining and validating bipolar disorder in the preschool period | Q40275830 | ||
| Substance P and the neurokinins: novel peptide neurotransmitters in psychopharmacology | Q40820944 | ||
| A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. | Q42625302 | ||
| Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo-controlled pilot study | Q43145175 | ||
| The role of serotonin transporter protein gene in antidepressant-induced mania in bipolar disorder: preliminary findings | Q43626488 | ||
| Screening for bipolar disorder in the community | Q44318544 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bipolar disorder | Q131755 |
| P304 | page(s) | 24-31 | |
| P577 | publication date | 2010-07-01 | |
| P1433 | published in | Postgraduate Medicine | Q7234297 |
| P1476 | title | Bipolar disorder: an update | |
| P478 | volume | 122 |
| Q38024792 | 14-3-3 proteins in neurological disorders. |
| Q44014376 | N-acetylcysteine for major depressive episodes in bipolar disorder |
| Q90109125 | Review of animal models of bipolar disorder that alter ion regulation |
| Q45764228 | Study of antidepressant-like activity of an enriched phloroglucinol fraction obtained from Hypericum caprifoliatum |
| Q41859677 | Validation of a specific measure to assess health-related quality of life in patients with schizophrenia and bipolar disorder: the 'Tolerability and quality of life' (TOOL) questionnaire |
Search more.